Stocks Overview

LAST PRICE
27.1700
TODAY'S CHANGE (%)
Trending Down-0.5800 (-2.0901%)

Bid / Lots
27.0000/ 1
Ask / Lots
27.6500/ 6
Open / Previous Close
27.8000 / 27.7500
Day Range
Low 26.9700
High 27.9700
52 Week Range
Low 15.9000
High 45.5800
Volume
1,414,961
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 27.75
Time	Volume	IMVT
09:32 ET	6713	27.8
09:34 ET	500	27.615
09:36 ET	2230	27.43
09:38 ET	1200	27.43
09:39 ET	1227	27.465
09:41 ET	1600	27.54
09:43 ET	400	27.54
09:45 ET	1000	27.58
09:48 ET	2265	27.65
09:50 ET	600	27.61
09:52 ET	4129	27.53
09:54 ET	500	27.58
09:56 ET	3168	27.635
09:57 ET	200	27.645
09:59 ET	1200	27.63
10:01 ET	600	27.6
10:03 ET	3676	27.59
10:06 ET	2234	27.605
10:08 ET	2265	27.635
10:10 ET	1600	27.6
10:12 ET	1400	27.56
10:14 ET	940	27.55
10:15 ET	5430	27.4
10:17 ET	11197	27.5
10:19 ET	2826	27.54
10:21 ET	6355	27.65
10:24 ET	2983	27.805
10:26 ET	13600	27.59
10:28 ET	7482	27.54
10:30 ET	1384	27.555
10:32 ET	5028	27.73
10:33 ET	300	27.75
10:35 ET	1506	27.8
10:37 ET	2300	27.75
10:39 ET	1700	27.71
10:42 ET	1359	27.755
10:44 ET	2000	27.7
10:46 ET	2852	27.63
10:48 ET	1400	27.734
10:50 ET	22601	27.745
10:51 ET	17021	27.79
10:53 ET	2127	27.75
10:55 ET	2107	27.705
10:57 ET	1427	27.62
11:00 ET	2782	27.685
11:02 ET	805	27.74
11:04 ET	100	27.78
11:08 ET	600	27.72
11:09 ET	3700	27.59
11:11 ET	700	27.57
11:13 ET	2292	27.62
11:15 ET	1699	27.51
11:18 ET	900	27.51
11:20 ET	1488	27.52
11:22 ET	500	27.5
11:24 ET	2651	27.44
11:26 ET	1110	27.45
11:27 ET	1100	27.49
11:29 ET	402	27.46
11:31 ET	2412	27.39
11:33 ET	2600	27.32
11:36 ET	6746	27.4
11:38 ET	700	27.45
11:40 ET	600	27.42
11:42 ET	2048	27.39
11:44 ET	1300	27.43
11:45 ET	2085	27.5
11:47 ET	1400	27.49
11:49 ET	1242	27.5
11:51 ET	1458	27.53
11:54 ET	2000	27.52
11:56 ET	2400	27.62
11:58 ET	400	27.6
12:00 ET	4500	27.56
12:02 ET	1402	27.53
12:03 ET	10629	27.55
12:05 ET	32100	27.525
12:07 ET	3090	27.55
12:09 ET	921	27.55
12:12 ET	3802	27.542
12:14 ET	16569	27.54
12:16 ET	13682	27.56
12:18 ET	300	27.555
12:20 ET	5338	27.615
12:21 ET	4344	27.57
12:23 ET	200	27.57
12:27 ET	3826	27.565
12:30 ET	1784	27.56
12:32 ET	312	27.61
12:34 ET	1533	27.59
12:36 ET	420	27.57
12:38 ET	300	27.572
12:39 ET	390	27.59
12:41 ET	100	27.59
12:43 ET	100	27.59
12:45 ET	3238	27.48
12:48 ET	12116	27.37
12:50 ET	1617	27.35
12:52 ET	1102	27.37
12:54 ET	1000	27.455
12:56 ET	200	27.48
12:57 ET	600	27.45
12:59 ET	838	27.49
01:01 ET	900	27.5
01:03 ET	100	27.525
01:06 ET	425	27.54
01:08 ET	200	27.525
01:10 ET	5475	27.605
01:12 ET	1100	27.58
01:14 ET	2823	27.625
01:15 ET	600	27.64
01:17 ET	200	27.65
01:19 ET	1879	27.63
01:21 ET	1099	27.68
01:24 ET	200	27.7
01:26 ET	160	27.68
01:28 ET	600	27.65
01:30 ET	400	27.6
01:32 ET	700	27.65
01:33 ET	3052	27.6
01:35 ET	1600	27.565
01:37 ET	560	27.6
01:39 ET	900	27.575
01:42 ET	5432	27.53
01:44 ET	7710	27.52
01:46 ET	1500	27.6
01:48 ET	400	27.64
01:50 ET	403	27.63
01:51 ET	1172	27.6
01:53 ET	2296	27.58
01:55 ET	400	27.56
01:57 ET	1170	27.58
02:00 ET	25626	27.65
02:02 ET	3099	27.65
02:04 ET	1008	27.645
02:06 ET	700	27.63
02:08 ET	4937	27.685
02:09 ET	100	27.66
02:11 ET	1468	27.665
02:13 ET	2079	27.605
02:15 ET	200	27.5915
02:18 ET	2169	27.575
02:20 ET	1730	27.505
02:22 ET	1718	27.44
02:24 ET	1243	27.435
02:26 ET	100	27.465
02:27 ET	300	27.47
02:29 ET	2275	27.47
02:31 ET	827	27.47
02:33 ET	4341	27.385
02:36 ET	1107	27.415
02:38 ET	700	27.49
02:40 ET	100	27.48
02:42 ET	1720	27.445
02:44 ET	1170	27.46
02:45 ET	3390	27.395
02:47 ET	3590	27.39
02:49 ET	1105	27.36
02:51 ET	839	27.37
02:54 ET	22039	27.395
02:56 ET	2701	27.34
02:58 ET	8523	27.34
03:00 ET	1443	27.34
03:02 ET	1300	27.34
03:03 ET	4693	27.34
03:05 ET	2944	27.27
03:07 ET	2681	27.22
03:09 ET	2767	27.26
03:12 ET	1134	27.24
03:14 ET	6382	27.23
03:16 ET	4432	27.22
03:18 ET	1000	27.24
03:20 ET	4627	27.3
03:21 ET	35511	27.42
03:23 ET	2841	27.39
03:25 ET	600	27.42
03:27 ET	7715	27.37
03:30 ET	877	27.34
03:32 ET	1680	27.37
03:34 ET	4545	27.295
03:36 ET	12537	27.25
03:38 ET	5614	27.2
03:39 ET	8642	27.25
03:41 ET	111999	27.21
03:43 ET	8234	27.115
03:45 ET	10837	27.04
03:48 ET	17818	27.01
03:50 ET	14683	27.015
03:52 ET	16878	27.14
03:54 ET	49660	27.23
03:56 ET	39747	27.15
03:57 ET	50608	27.16
03:59 ET	39167	27.17

Data delayed at least 15 minutes.

Mar 28, 2024
- DJ Immunovant Initiated at Outperform by Oppenheimer, from 6:59AM ET on Thursday Mar 28, 2024 by Dow Jones
  6:59AM ET on Thursday Mar 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesIMVT Immunovant Inc	4.0B	-14.9x	---
United StatesMDGL Madrigal Pharmaceuticals Inc	4.1B	-9.7x	---
United StatesNUVL Nuvalent Inc	4.2B	-30.9x	---
United StatesBBIO BridgeBio Pharma Inc	4.5B	-6.3x	---
United StatesALPN Alpine Immune Sciences Inc	4.2B	-94.6x	---
United StatesIBRX Immunitybio Inc	3.4B	-6.5x	---
As of 2024-04-26

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for patients with autoimmune diseases. Its product pipeline includes batoclimab (IMVT-1401), and IMVT-1402, both of which are novel, fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor (FcRn). Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD). IMVT-1402 is a fully human monoclonal antibody that inhibits FcRn. IMVT-1402 has also been observed in nonclinical studies to reduce IgG antibody levels. IMVT-1402 is delivered as a 2 mL simple subcutaneous injection.

Contact Information

Headquarters: 320 West 37Th StreetNEW YORK, NY, United States 10018
Phone: 917-580-3099
Fax: 302-636-5454

Executives

Executive Chairman of the Board: Frank Torti
Chief Executive Officer of IMVT Corporation, Director: Peter Salzmann
Chief Financial Officer: Eva Barnett
Chief Technology Officer: Jay Stout
Chief Development Officer: Julia Butchko

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$4.0B
Revenue (TTM)	$0.00
Shares Outstanding	145.3M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.74
EPS	$-1.83
Book Value	$2.78
P/E Ratio	-14.9x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Immunovant Inc
NASDAQ:IMVTUnited States

Search Criteria

Charts

Recent News

Mar 28, 2024

DJ Immunovant Initiated at Outperform by Oppenheimer, from 6:59AM ET on Thursday Mar 28, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar